-
Mashup Score: 1Evaluating Anticoagulant Strategies for Atrial Fibrillation in Patients With Cancer: Challenges and Opportunities∗ - 2 year(s) ago
Corresponding Author
Source: JACC: CardioOncologyCategories: Expert Picks, Latest HeadlinesTweet
-
Mashup Score: 15Outcomes by Class of Anticoagulant Use for Nonvalvular Atrial Fibrillation in Patients With Active Cancer: - 2 year(s) ago
Abstract Background The choice of anticoagulant agent for patients with nonvalvular atrial fibrillation (NVAF) in the setting of active cancer has not been well studied. Objectives The aim of this …
Source: JACC: CardioOncologyCategories: Expert Picks, Latest HeadlinesTweet-
Ever wondered what is the best #anticoagulant is best for #cancer patients with #AFib? #DOAC and #warfarin have similar risks for CVA, ICH, & GIB for #NVAF. https://t.co/BSAkYM6GYo #JACCCardioOnc #CardioOnc #CardioTwitter @AdamPotterMDPhD @EKoutroumpakis @anita_deswal @PalaskasN https://t.co/6MhKSDgILc
-
-
Mashup Score: 1Imaging-Based Obesity Assessment for Risk Factor Stratification and Prognostication in Malignancy: - 2 year(s) ago
IntroductionWe read with interest the paper titled “Association of Cardiometabolic Disease With Cancer in the Community” by Liu et al.1 We congratulate them on their successful work and wish to add to their findings.We agree that body mass index (BMI) is substandard in providing an accurate measure of obesity given its influence by age, sex, and ethnicity. Liu et al1 demonstrate the importance of…
Source: JACC: CardioOncologyCategories: Expert Picks, Latest HeadlinesTweet
-
Mashup Score: 1How to Manage Cisplatin-Based Chemotherapy–Related Cardiovascular Disease in Patients With Testicular Cancer: - 2 year(s) ago
Highlights • Patients with advanced testicular cancer receive cisplatin-based chemotherapy with a high rate of cure. • Cisplatin-based chemotherapy increases risks of acute vascular complications a…
Source: JACC: CardioOncologyCategories: Cardiac Surgery, Latest HeadlinesTweet
-
Mashup Score: 1Cardio-Oncology in Portugal: A Rising Tide - 2 year(s) ago
IntroductionNeither floods nor plagues, famines nor cataclysms, nor even the eternal wars of century upon century, have been able to subdue the persistent advantage of life over death—Gabriel Garcia Marquez in his acceptance speech for the Nobel Prize for Literature, 1982Cardiovascular and oncological diseases are the 2 most common causes of mortality and morbidity in developed nations. Patients…
Source: JACC: CardioOncologyCategories: Expert Picks, Latest HeadlinesTweet
-
Mashup Score: 5Consensus-Based Cardiomyopathy Care in Childhood Cancer Survivors: When You Don’t Have a Roadmap, Ask Directions∗ - 2 year(s) ago
Corresponding Author
Source: JACC: CardioOncologyCategories: Expert Picks, Latest HeadlinesTweet-
How do we reason through real-world conundrums in the cardiac care of childhood cancer survivors? Read about the potential roadmaps for #cardiomyopathy care in this issue of #JACCCardioOnc: https://t.co/7ZYl0hz1Dv #CardioOnc #cvPed #CardioTwitter #childhoodcancer @DrThomasRyan https://t.co/9N80AYzRCe
-
-
Mashup Score: 1Considerations of Competing Risks Analysis in Cardio-Oncology Studies: JACC: CardioOncology State-of-the-Art Review - 2 year(s) ago
Abstract Cardio-oncology research studies often require consideration of potential competing risks, as the occurrence of other events (eg, cancer-related death) may preclude the primary event of in…
Source: JACC: CardioOncologyCategories: Cardiac Surgery, Latest HeadlinesTweet-
#CardioOnc research studies often require consideration of potential competing risks, as the occurrence of other events (eg cancer-related death) may preclude the primary event of interest (eg CV outcome). https://t.co/j6Zm1dIPOu #JACCCardioOnc #MedTwitter @KDGetzPhD @UPennDBEI https://t.co/jVKwcFkCYB
-
-
Mashup Score: 2Optimal Timing of a Physical Exercise Intervention to Improve Cardiorespiratory Fitness: During or After Chemotherapy - 2 year(s) ago
Abstract Background Despite the widely acknowledged benefit of exercise for patients with cancer, little evidence on the optimal timing of exercise on adverse effects of cancer treatment is availab…
Source: JACC: CardioOncologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 4How to Manage and Monitor Cardiac Dysfunction in Patients With Metastatic HER2-Positive Breast Cancer: - 2 year(s) ago
Highlights • Targeted therapies improve clinical outcomes in HER2+ metastatic breast cancer. • There is thus far minimal signal of increased risk of cardiotoxicity from novel HER2 targeted therapie…
Source: JACC: CardioOncologyCategories: Expert Picks, Latest HeadlinesTweet-
In this new #JACCCardioOnc How To case, Dr. @sdent_duke et al. illustrate their approach to the Tx of HER2+ metastatic BC in the setting of LVD and propose cardiac surveillance strategies. https://t.co/ofF6R3fSGP #CardioOnc #BCsm #BCAM @avirupguha @LauraAtHome @HeatherMoore16 https://t.co/H1JgTpl9N8
-
-
Mashup Score: 0Optimal Timing of a Physical Exercise Intervention to Improve Cardiorespiratory Fitness: During or After Chemotherapy - 2 year(s) ago
Abstract Background Despite the widely acknowledged benefit of exercise for patients with cancer, little evidence on the optimal timing of exercise on adverse effects of cancer treatment is availab…
Source: JACC: CardioOncologyCategories: Hematologists1, Latest HeadlinesTweet
Drs. @DebSiegal and @DarrylLeong provide their commentary on the importance of accurately determining the optimal #anticoagulant for patients with #AFib and #cancer. https://t.co/mGIRpfWMiE #JACCCardioOnc #CardioOnc #CardioTwitter